JPS5872522A - Preparation of iron-enriched nutriment - Google Patents

Preparation of iron-enriched nutriment

Info

Publication number
JPS5872522A
JPS5872522A JP56170600A JP17060081A JPS5872522A JP S5872522 A JPS5872522 A JP S5872522A JP 56170600 A JP56170600 A JP 56170600A JP 17060081 A JP17060081 A JP 17060081A JP S5872522 A JPS5872522 A JP S5872522A
Authority
JP
Japan
Prior art keywords
iron
nutriment
enriched
chlorella
nutritional supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56170600A
Other languages
Japanese (ja)
Other versions
JPS6313407B2 (en
Inventor
Takashi Tomikanehara
冨金原 孝
Eiichi Matsuura
松浦 栄一
Kazuyasu Miki
三木 和保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIKAMITSU HONSHA KK
Original Assignee
SHIKAMITSU HONSHA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIKAMITSU HONSHA KK filed Critical SHIKAMITSU HONSHA KK
Priority to JP56170600A priority Critical patent/JPS5872522A/en
Publication of JPS5872522A publication Critical patent/JPS5872522A/en
Publication of JPS6313407B2 publication Critical patent/JPS6313407B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:The titled nutriment, containing a nicrobial protein in which iron is bonded as a chelate as an iron active constituent in a nutriment consisting of a suitable composition, and capable of improving the iron deficient anemic state. CONSTITUTION:An iron-enriched nutriment containing a microbial protein, e.g. chlorella or yeast, in which iron is bonded as a chelate, as an active constituent for iron supply in a nutriment consisting of a suitable composition, e.g. an enzyme capable of decomposing the cellular membrane. The nutriment has remarkably improved absorbability and very remarkable safety for the living body, and is particularly optimum for improving the anemia in young pigs. The iron content may be adjusted to 1,300mg% or less concentration by incorporating an adequate nutriment therewith. The nutriment is applicable as a convalescent agent for iron deficient anemia.

Description

【発明の詳細な説明】 本発明は、鉄火性貧血状態を改善するための鉄強化栄養
剤の製造法に関するものであって、特に子豚の貧血改善
に役立たせるものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing an iron-enriched nutritional supplement for improving iron-induced anemia, and is particularly useful for improving anemia in piglets.

子豚の出生時のヘモグロビン量(g/d l )は、成
豚と同様な正常値を通常示すが、微乳開始後から該ヘモ
グロビン量が急激に減少し、生後三日月にはその値は正
常値の70−程度になり、明らかに鉄火性貧血状態を呈
すると共に、爾後この状態がなかなか回復しないためi
と子豚の発育に悪影響をもたらすと云われている。 そ
こで従来にあっては、該ヘモグロビン量を正常値にする
ためにデキストラン鉄(鉄分として100mg程度)の
筋肉内注射を行なうことを通例とした。
The amount of hemoglobin (g/dl) at birth of piglets usually shows the same normal value as that of adult pigs, but the amount of hemoglobin decreases rapidly after the beginning of small-feeding, and the value becomes normal by the third month of life. The value reached around 70-70, clearly showing a state of iron-fired anemia, and since this state did not recover easily, i
It is said that this has a negative effect on the growth of piglets. Therefore, conventionally, it has been customary to perform intramuscular injection of iron dextran (approximately 100 mg of iron) in order to bring the hemoglobin level to a normal value.

然し乍ら、元来子豚は、出生時から腸管内の鉄吸収作用
はすこぶる旺盛であり、前記の如き人為的の注射に依存
しなくても、適当な鉄剤を経口的に与えれば、鉄は栄養
分として十分に吸収され、体内の鉄バランスを良好な状
態に保つことができる能力を有している。 しかも、前
記した人為的注射に依存するよりも鉄剤の経口投与の方
が生理的に自然であり、従って、適切な経口鉄剤の開発
が強く要望されているのが実情である。
However, piglets have a very strong ability to absorb iron in their intestinal tracts from the time they are born, and even if they do not rely on artificial injections as mentioned above, if they are given an appropriate iron supplement orally, they can absorb iron as nutrients. It is well absorbed and has the ability to maintain a good iron balance in the body. Furthermore, oral administration of iron preparations is physiologically more natural than relying on the artificial injections described above, and therefore, there is a strong demand for the development of appropriate oral iron preparations.

処で、経口鉄剤であるが、これは無機あるいは有機の鉄
塩からもできるが、これらのものは鉄の吸収率があまり
良くなく、かつ生理的にも好ましいものではなく、場合
によっては有害作用も現われる。
Oral iron preparations can also be made from inorganic or organic iron salts, but these do not have a very good iron absorption rate, are not physiologically favorable, and may have harmful effects in some cases. also appears.

本発明は、鉄を蛋白法にキレート結合させて用いた場合
、吸収率が著しく向上化され、しかも生体に対する安全
性が極めて顕著であることを確認し、これに基き、子豚
の貧血改善に最適さする鉄強化栄養剤の製造を可能なら
しめたものである。
The present invention has confirmed that when iron is used in a chelate bond with a protein method, the absorption rate is significantly improved and the safety for the living body is extremely remarkable.Based on this, the present invention is aimed at improving anemia in piglets. This makes it possible to produce optimal iron-fortified nutrients.

すなわち本発明方法は、適宜の配合から成る栄養剤中に
、鉄をキレート結合したクロレラ、酵母等の微生物蛋白
体を鉄補給用有効成分として含有させることに依り、栄
養剤中の鉄分の強化を図り、また、必要に応じて使用栄
養剤に細胞膜分解酵素を添加したことを特徴とする鉄強
化栄養剤の製造法に係るものである。
In other words, the method of the present invention enhances the iron content in a nutritional supplement by containing microbial proteins such as chlorella and yeast that have chelated iron in the nutritional supplement as an active ingredient for iron supplementation. The present invention relates to a method for producing an iron-enriched nutrient, which is characterized in that a cell membrane-degrading enzyme is added to the nutrient used as necessary.

飼料として使用に供されているクロレラ、酵母などの微
生物蛋白体を用い、これらの微生物体に鉄イオンをキレ
ートさせる方法に関し、クロレラ藻体を例にとって具体
的に説明すれば下記の通りである。 賞、酵母に対する
鉄イオンのキレートもこれと同様にして行なうものであ
るつ 硫酸鉄(Fe80m、)H,O)20gを81の水に溶
かしこれに乾燥クロレラ藻体IKg程度を加えて攪拌し
ながら常温でしばらく放置した後、上澄液を除いた残渣
(鉄キレートクロレラ)に水を加えて洗浄することに依
り水中に溶解している未反応の硫酸鉄を除却し、このよ
うな操作を繰返しておこなうことに依り残漬を分離した
後、該残漬に対する乾燥処理を施せば、鉄がキレートさ
れたクロレラ粉末が得られる。(、収量80チ程度)。
A method for chelating iron ions to microbial proteins such as chlorella and yeast that are used as feed will be specifically explained below using chlorella algae as an example. Chelation of iron ions to yeast is carried out in the same manner as above.Dissolve 20g of iron sulfate (Fe80m, )H,O) in 81g of water and add approximately 1kg of dried Chlorella algae to this, stirring while stirring. After leaving it at room temperature for a while, the supernatant was removed and the residue (iron chelate chlorella) was washed by adding water to remove unreacted iron sulfate dissolved in the water, and this operation was repeated. After separating the residue by drying, the remaining residue is subjected to a drying treatment to obtain iron-chelated chlorella powder. (Yield about 80 cm).

 この鉄キレートクロレラ粉末中の鉄分は、使用原料の
クロレラによって多少異なるが、概ね本品100g中1
3001F1g程度でキレートされた鉄の量はl OO
0mg以上であることが、原子吸光分析により確認され
た。 伺、酵母を用いて同様に鉄をキレートさせると、
酵母にキレートされた鉄の量は500〜600q程度で
あることが、原子吸光分析により確認され、キレートさ
れる鉄の量はクロレラの方が多いことが確かめられた。
The iron content in this iron chelate chlorella powder varies slightly depending on the chlorella raw material used, but it is approximately 1% in 100g of this product.
The amount of iron chelated with about 1g of 3001F is l OO
It was confirmed by atomic absorption spectrometry that the amount was 0 mg or more. However, when iron is similarly chelated using yeast,
It was confirmed by atomic absorption spectrometry that the amount of iron chelated by yeast was about 500 to 600q, and it was confirmed that the amount of iron chelated by chlorella was larger.

処で、クロレラは食品中では鉄の含炭が比較的高いもの
として知られているが(loog中鉄分100〜300
mg)、上記の方法によれば鉄の含炭を5〜lO倍に強
化させたことが確認される。 また、前記の鉄キレート
クロレラ粉末の鉄火性貧血に対する投与効果について、
白ネズミを用いた試験を行なった処、鉄キレートクロレ
ラ粉末の投与量はクロレラ自体の投与量の騒〜ににする
ことができ、かつ鉄キレートクロレラの生体内での吸収
率が極めて高いことが確認された。
However, chlorella is known to have a relatively high iron and carbon content in foods (loog iron content is 100 to 300).
mg), it is confirmed that the above method strengthens the carbon content of iron by 5 to 10 times. In addition, regarding the administration effect of the above-mentioned iron chelate chlorella powder on iron-induced anemia,
A test using white rats revealed that the dose of iron chelate chlorella powder can be made as low as the dose of chlorella itself, and that the in vivo absorption rate of iron chelate chlorella is extremely high. confirmed.

本発明によれば、鉄分を1300 mg%以下の濃度に
適宜の他の栄養剤の配合により調整することができ、鉄
火性貧血の回復剤として広い範囲に適用できるものであ
るが、以下、本発明方法の配合の具体的実施例を述べる
According to the present invention, the iron content can be adjusted to a concentration of 1300 mg% or less by blending other nutrients as appropriate, and can be widely applied as a recovery agent for iron-induced anemia. A specific example of the composition of the invention method will be described.

実施例1 クロレラ藻体を用いて前記の方法で鉄キレートクロレラ
粉末を製造し、この粉末700gをとり、これに他の栄
養剤として酵母と小麦敵芽粉末(ローストしたもの)を
それぞれ150gを加えて混和し、これより鉄強化栄養
剤IKgを得た。 尚、鉄の含炭は原子吸光分析の結果
、100g中8 ’78mgであった。
Example 1 Iron chelate chlorella powder was produced by the method described above using chlorella algae, and 700 g of this powder was taken, and 150 g each of yeast and wheat bud powder (roasted) were added thereto as other nutrients. and mixed to obtain IKg of iron-enriched nutritional supplement. As a result of atomic absorption spectrometry, the carbon content of iron was 8'78 mg per 100 g.

実施例2 酵母菌体を用いて前記の方法で鉄キレート酵母粉末を製
造し、この粉末700gをとり、これに他の栄養剤とし
てクロレラ及び小麦七芽粉末をそれぞれ150gを加え
て混和し、これにより鉄強化栄養剤IKgを得た。 賞
、鉄の含炭は原子吸光分析の結果、100 gcp45
3mgであった。
Example 2 Iron chelate yeast powder was produced using yeast cells in the above-described method. 700 g of this powder was taken, and 150 g each of chlorella and wheat seven sprout powder were added thereto as other nutritional supplements and mixed. Iron-enriched nutritional supplement IKg was obtained. Award: As a result of atomic absorption analysis, the carbon content of iron is 100 gcp45
It was 3 mg.

実施例3 実施例1による鉄強化栄養剤I Kgに対し、細胞膜分
解酵素としてキタラーゼ3gを加えて混和して鉄強化栄
養剤を得たo 伺、鉄の含炭は実施例1と同じである。
Example 3 An iron-enriched nutrient was obtained by adding and mixing 3 g of chitalase as a cell membrane degrading enzyme to I kg of the iron-enriched nutrient prepared in Example 1.The carbon content of iron was the same as in Example 1. .

実施例4 実施例2による鉄強化栄養剤1″詔に対し、細胞膜分解
酵素としてキターラーゼ3gを加えて混和して鉄強化栄
養剤を得た。 伺、鉄の含炭は実施例2と同じである。
Example 4 An iron-enriched nutrient was obtained by adding and mixing 3 g of chytalase as a cell membrane degrading enzyme to 1" of the iron-enriched nutrient according to Example 2. The carbon content of iron was the same as in Example 2. be.

処で、実施例1及び2で用いた栄養剤であるが、と1れ
番こクロレラ、エキスの如き動物生長促進作用を有する
物質を添加しておくことは有意義なことであり、本発明
においてはこのような物質を具えた栄養剤を用いても良
い。
However, in the nutritional supplements used in Examples 1 and 2, it is significant to add substances that have an animal growth promoting effect, such as chlorella extract, and in the present invention. Nutritional supplements containing such substances may also be used.

次に、本発明に於ける上記実施例3により製された鉄強
化栄−養剤を用いた子豚の貧血改善効果の1試験結果化
ついて詳述する。
Next, a detailed description will be given of the results of a test on the effect of improving anemia in piglets using the iron-enriched nutrient prepared in Example 3 of the present invention.

分べん直後の子豚各8頭を用いて試験区(鉄強化栄養剤
摂取)と対照区とに分け、出生後より20日間の飼育結
果を観、察した。
Eight piglets were divided into a test group (intake of iron-enriched nutrients) and a control group using eight piglets immediately after separation, and the results of rearing for 20 days after birth were observed and observed.

試験区は一頭当り1日1gの本発明に依る鉄強化栄養剤
(実施例3に依るもの)を摂取させて授乳させ、対照区
は授乳だけとし、両者とも20目に離乳させた。
In the test group, each animal received 1 g of the iron-enriched nutritional supplement according to the present invention (according to Example 3) per day and was allowed to breastfeed, while in the control group, animals were allowed to breastfeed only, and both animals were weaned on the 20th day.

試験期間中の貧血の回復状態をヘモグロビン量(シアン
、メトヘモグロビン法)、ヘマトクリット値(毛細管−
高速遠心法)、網状赤血球値(プレツカ−法)および血
清鉄(松原民法)により測定して観察した。
The state of recovery from anemia during the test period was measured by hemoglobin level (cyan, methemoglobin method) and hematocrit value (capillary -
Observations were made using the high-speed centrifugation method), reticulocyte value (Pletsker method), and serum iron (Matsubara Minho).

上記の各測定結果を示すと、ヘモグロビン量(g/d/
)、ヘマトクリ−/)値(%)および網状赤血球値(チ
)は第1図乃至第3図に示す通りであり、血清鉄は、試
験区では106μg/dlでありまた対照区では233
μg/61であった。
The above measurement results show that the amount of hemoglobin (g/d/
), hematocrit/) value (%), and reticulocyte value (ch) are as shown in Figures 1 to 3, and serum iron was 106 μg/dl in the test group and 233 μg/dl in the control group.
It was μg/61.

第1図及び第2図により明らかなように、鉄火性貧血の
指標となるヘモグロビン量およびヘマトクリット値は、
本発明法による鉄強化栄養剤の20日間の投与に基き、
明らかに正常値以上まで回復していることが確認される
。 また、骨髄の造血状態をみると、網状赤血球値(こ
の値が高いものはど幼若赤血球数が〜多く、正常の赤血
球数が少ない)も対照区より低い値を示しており、赤血
球の造血機能も良好であることが示されている。 更に
、血清鉄の濃度も上記のように明らかに試験区の方がは
るかに高い値になっている。
As is clear from Figures 1 and 2, the amount of hemoglobin and hematocrit value, which are indicators of iron-induced anemia, are as follows:
Based on the administration of iron-fortified nutritional supplement according to the method of the present invention for 20 days,
It is confirmed that the condition has clearly recovered to above normal values. In addition, looking at the hematopoietic status of the bone marrow, the reticulocyte value (those with high values have a high number of immature red blood cells and a low number of normal red blood cells) was lower than the control group, indicating that red blood cell hematopoiesis. It has also been shown to function well. Furthermore, as mentioned above, the serum iron concentration was clearly much higher in the test group.

以上要約すると、貧血状態は本発明法による鉄強化栄養
剤の20日間の投与に依って完全に回復していると判定
される。 また、外観的にも対照区の子豚に比べて試験
・区の子豚は毛及び皮膚の色つやが良好であり、かつ活
力も優れている健康状態であることが一見して確認され
、これ番こより本発明法による鉄強化栄養剤の貧血回復
に対する効果は極めて顕著であることが知れた。
In summary, it was determined that the anemic state was completely recovered by administering the iron-fortified nutritional supplement according to the method of the present invention for 20 days. In addition, it was confirmed at a glance that the piglets in the test group had better coat and skin color and luster than piglets in the control group, and were in a healthier state with superior vitality. It was found from Banko that the effect of the iron-fortified nutritional supplement according to the method of the present invention on anemia recovery is extremely remarkable.

以上詳述した本発明方法に依り製造される鉄強化栄養剤
は、経口的に一生体内に取入れられかつその吸収率も極
めて良く、子豚に対する貧血状態の改善に卓越した効果
を奏するものであるから、本発明方法は子豚等動物用の
鉄強化栄養剤の製造法として正に最適なものである。
The iron-enriched nutritional supplement produced by the method of the present invention described in detail above can be orally taken into the body throughout life, has an extremely good absorption rate, and is extremely effective in improving anemia in piglets. Therefore, the method of the present invention is truly optimal as a method for producing iron-fortified nutrients for animals such as piglets.

【図面の簡単な説明】[Brief explanation of the drawing]

図は本発明方法により製された鉄強化栄養剤に依る子豚
に対する貧血改善効果確認のための試験結果を示すもの
であって、第1図はヘモグロビン量の試験結果、第2図
はへマドクリット値の試験結果、第3図は網状赤血球値
の試験結果を表わしたものである。 第1図 ヘモグロビン量(g/ dl) 0日  10日  加日 第2図 ヘマトクリット値(%) 第3図 網状赤血球値(チ) 0日    10日   20日
The figures show the test results for confirming the anemia improvement effect on piglets of the iron-enriched nutritional supplement produced by the method of the present invention. Figure 3 shows the test results for reticulocyte values. Figure 1 Hemoglobin amount (g/dl) Day 0 10 Day Canada Figure 2 Hematocrit value (%) Figure 3 Reticulocyte value (CH) Day 0 10 Day 20

Claims (4)

【特許請求の範囲】[Claims] (1)適宜め配合から成る栄養剤中に、鉄をキレート結
合した微生物蛋白体を鉄補給有効成分として含有させて
栄養剤中の鉄分の強化を計ることを特徴とする鉄強化栄
養剤の製造法。
(1) Manufacture of an iron-enriched nutritional supplement, which is characterized by containing a microbial protein chelating iron as an effective iron-replenishing ingredient in a nutritional supplement composed of an appropriate formulation, thereby enhancing the iron content in the nutritional supplement. Law.
(2)微生物蛋白体としてクロレラを用いて成る特許請
求の範囲第1項記載の鉄強化栄養剤の製造法。
(2) A method for producing an iron-enriched nutritional supplement according to claim 1, which uses chlorella as the microbial protein.
(3)微生物蛋白体として酵母を用いて成る特許請求の
範囲第1項記載の鉄強化栄養剤の製造法。
(3) A method for producing an iron-enriched nutritional supplement according to claim 1, which uses yeast as the microbial protein.
(4)栄養剤として細胞膜分解酵素を添加したものを用
いて成る特許請求の範囲第1乃至第3項記載の鉄強化栄
養剤の製造法。
(4) A method for producing an iron-enriched nutrient according to claims 1 to 3, which uses a nutrient to which a cell membrane degrading enzyme is added.
JP56170600A 1981-10-24 1981-10-24 Preparation of iron-enriched nutriment Granted JPS5872522A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56170600A JPS5872522A (en) 1981-10-24 1981-10-24 Preparation of iron-enriched nutriment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56170600A JPS5872522A (en) 1981-10-24 1981-10-24 Preparation of iron-enriched nutriment

Publications (2)

Publication Number Publication Date
JPS5872522A true JPS5872522A (en) 1983-04-30
JPS6313407B2 JPS6313407B2 (en) 1988-03-25

Family

ID=15907846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56170600A Granted JPS5872522A (en) 1981-10-24 1981-10-24 Preparation of iron-enriched nutriment

Country Status (1)

Country Link
JP (1) JPS5872522A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004071519A1 (en) * 2003-01-14 2004-08-26 Bruneau Francois Photosynthetic micro-organisms enriched with biologically-active molecules, preparation method thereof and uses of same
KR100789288B1 (en) 2005-06-16 2007-12-28 이상범 An Yeast Solution and Yeast-Mineral Complex Having Immunostimulatory Activity, And the Preparation Method Thereof
KR100860778B1 (en) * 2007-04-16 2008-09-30 이상범 Composition of feed stuff containing an Yeast Solution and Yeast-Mineral Complex having Immunostimulatory Activity
JP2009248289A (en) * 2008-04-10 2009-10-29 Murata Mach Ltd Parallel mechanism

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726742A (en) * 1980-07-24 1982-02-12 Mitsubishi Heavy Ind Ltd Method and device for magnetic-particle inspection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726742A (en) * 1980-07-24 1982-02-12 Mitsubishi Heavy Ind Ltd Method and device for magnetic-particle inspection

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004071519A1 (en) * 2003-01-14 2004-08-26 Bruneau Francois Photosynthetic micro-organisms enriched with biologically-active molecules, preparation method thereof and uses of same
KR100789288B1 (en) 2005-06-16 2007-12-28 이상범 An Yeast Solution and Yeast-Mineral Complex Having Immunostimulatory Activity, And the Preparation Method Thereof
KR100860778B1 (en) * 2007-04-16 2008-09-30 이상범 Composition of feed stuff containing an Yeast Solution and Yeast-Mineral Complex having Immunostimulatory Activity
JP2009248289A (en) * 2008-04-10 2009-10-29 Murata Mach Ltd Parallel mechanism

Also Published As

Publication number Publication date
JPS6313407B2 (en) 1988-03-25

Similar Documents

Publication Publication Date Title
Henry et al. Relative bioavailability of manganese in a manganese-methionine complex for broiler chicks
CN102987094A (en) Chinese herbal medicament immunopotentiator for high-density breeding of grass carp and preparation method thereof
CN105996009B (en) A kind of antioxidant and anti-aging SOD nanometer selenium peptide combinations and preparation method thereof
CN111772064A (en) Compound feed for preventing rotten body disease of raw fish and application thereof
CN107495053A (en) A kind of preparation method of compound high calcium protein powder preparation
EP0292052A2 (en) Fish feed, procedure for producing same, and feeding method
CN105878397A (en) Composition capable of regulating transportation stress of cattle and sheep
KR20080110129A (en) Food composition for stimulating growth by balancing between nutritional ingredient and growth stimulating ingredient
CN106923082A (en) A kind of feed for preventing and treating liver and gall syndrome of fish
JPS58857B2 (en) Fish feed and its manufacturing method
JPS60196157A (en) Food containing euglena
KR101252630B1 (en) Useful composition for growth and development of children and youths
JPS5872522A (en) Preparation of iron-enriched nutriment
KR100509983B1 (en) Healthy food composition for accelerating growth
CN112250774A (en) Preparation method of pumpkin polysaccharide chromium-selenium complex, product and application thereof
CN107212187A (en) The straw pulp and its processing method of a kind of promotion fish growth
KR101637525B1 (en) Composition of Supplementary Feed for Herbivores Containing Ginseng Steaming Extract
CN111714470A (en) Sustained-release ethylenediamine tetraacetic acid iron sodium premix for animals and preparation method thereof
CN109275806A (en) A kind of tilapia feed
CN115989873A (en) Nutritional composition for pregnant and lying-in women and preparation method and application thereof
CN108402307A (en) A kind of feed and preparation method thereof improving goat meat
JPH0651628B2 (en) Nutritional composition
CN110367404A (en) A kind of Chinese herbal medicine composite feeding promoting agent and its processing technology
Shanmugasundaram et al. Nutritional evaluation of ethanol extracted Madhuca (Madhuca butyraceae) seed flour
CN109480113A (en) One kind can improve pet dog anaemia jelly and preparation method thereof